Medgenics, Inc. (NYSE MKT: MDGN and AIM: MEDU, MEDG) (the “Company” or “Medgenics”), the developer of a novel platform technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced that Andrew L. Pearlman, Ph.D., President and Chief Executive Officer of Medgenics, will be presenting a corporate overview at the 12th Annual Needham Healthcare Conference taking place at the Westin Grand Central in New York City from April 30-May 1, 2013. Dr. Pearlman’s presentation will take place at 5:00 p.m. on April 30th.
